Stockscreener 앱 받기
0.2542
15.55%
0.0342
시간 외 거래:
.28
0.0258
+10.15%
전일 마감가:
$0.22
열려 있는:
$0.22
하루 거래량:
1.50M
Relative Volume:
0.34
시가총액:
$1.18M
수익:
$75,000
순이익/손실:
$-42.41M
주가수익비율:
-0.00141
EPS:
-179.8206
순현금흐름:
$-18.47M
1주 성능:
+2.21%
1개월 성능:
-42.90%
6개월 성능:
-96.84%
1년 성능:
+0.00%
1일 변동 폭
$0.22
$0.264
1주일 범위
$0.2131
$0.2839
52주 변동 폭
$0.2131
$166.50
Profusa Inc Stock (PFSA) Company Profile
명칭
Profusa Inc
전화
212-494-9022
주소
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.2542 | 1.10M | 75,000 | -42.41M | -18.47M | -179.82 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc 주식(PFSA)의 최신 뉴스
Why Did PFSA Stock Surge 150% Today? - Stocktwits
Profusa submits response to European regulator for device approval - Investing.com UK
Profusa submits response to European regulator for device approval By Investing.com - Investing.com Australia
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform - The Manila Times
Profusa Submits Response Package to GMED as Part of Ongoing Ce Mark Review Process for Lumee Oxygen Platform - marketscreener.com
Profusa CEO urges shareholders to vote on Nasdaq listing proposals By Investing.com - Investing.com Nigeria
Profusa CEO urges shareholders to vote on Nasdaq listing proposals - Investing.com
Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting - The Manila Times
Profusa vote tied to Nasdaq listing efforts, PanOmics asset deal - Stock Titan
Profusa, Inc. Files 8-K: Advance Notice for Common Stock Purchase Under Equity Line Agreement with Ascent Partners, Nasdaq Listed (PFSA) - Minichart
Profusa (NASDAQ: PFSA) registers 179.3M shares; Ascent holds majority - Stock Titan
Profusa Taps Equity Line With Dilutive True-Up Mechanism - TipRanks
Profusa secures temporary equity purchase terms with Ascent under amended SPA - TradingView
Profusa (PFSA) adjusts Ascent equity line with caps, VWAP and true-up terms - Stock Titan
Profusa (PFSA) affiliates report 9.99% ownership; reorg adds Eagle Claw - Stock Titan
Profusa to acquire multi-omics platform, partners with Mayo Clinic - Investing.com
PFSA Stock Chart | PROFUSA INC (NASDAQ:PFSA) - ChartMill
PFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
Profusa Inc. (PFSA) Slips 3.56% as Stock Approaches Key Support at $0.33Fibonacci Arc - The Legal Advocate
Profusa Shares Below 40 Cents as Nasdaq Deadline Nears - Bez Kabli
Profusa Inc. (PFSA) Slides 4.7% as Stock Tests Key Support at $0.33Ending Diagonal - newsline.com
Profusa Inc. (PFSA) Facing Resistance at $0.38 as Shares Dip 3.21%Volume Breakout Ideas - newsline.com
PFSA | Profusa, Inc. Common Stock Executive Compensation - Quiver Quantitative
[ARS] Profusa, Inc. SEC Filing - Stock Titan
Profusa (NASDAQ: PFSA) eyes major reverse split, $30M PanOmics stock acquisition and note conversion - Stock Titan
Profusa Amends PanOmics Acquisition Terms to Reduce Dilution - TipRanks
Profusa Amends $30 Million Asset Purchase of PanOmics Assay, Drops 12% Management Equity Grant - TradingView
[8-K] Profusa, Inc. Reports Material Event - Stock Titan
Profusa Inc. (PFSA) Edges Higher, Testing Key Resistance at $0.40Low Volatility Picks - The Legal Advocate
PFSA Should I Buy - Intellectia AI
Profusa, Inc. Submits Advance Notice for Equity Line Share Purchase with Ascent Partners Fund LLC – SEC Filing 8-K May 18, 2026 - Minichart
Profusa submits equity purchase notice to Ascent Partners under credit agreement - Investing.com Nigeria
Profusa (NASDAQ: PFSA) registers 179.3M resale shares; Ascent equity line terms detailed - Stock Titan
Profusa Taps Equity Line for Near-Term Liquidity - TipRanks
Profusa submits advance notice to Ascent for up to 9.99% equity purchase with true-up mechanism - TradingView
Profusa (NASDAQ: PFSA) details May equity line share purchase terms - Stock Titan
Number of shareholders of Profusa, Inc. – NASDAQ:PFSA - TradingView
Profusa Transfers Nasdaq Listing Amid Ongoing Compliance Uncertainty - The Globe and Mail
PFSA Financials: Income Statement, Balance Sheet & Cash Flow | Profusa Inc - Stock Titan
Profusa, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Profusa (NASDAQ: PFSA) Q1 2026 loss deepens amid going concern and Nasdaq listing pressure - Stock Titan
Profusa, Inc. Announces Transfer to Nasdaq Capital Market to Ensure Continued Listing Compliance - Minichart
Profusa to Transfer Listing to The Nasdaq Capital Market Effective May 15, 2026 - TradingView
Profusa (Nasdaq: PFSA) shifts stock listing to Nasdaq Capital Market tier - Stock Titan
Profusa moves to Nasdaq Capital Market amid compliance efforts By Investing.com - Investing.com Australia
Profusa moves to Nasdaq Capital Market amid compliance efforts - Investing.com
Profusa Announces Listing Transfer to The Nasdaq Capital Market - The Manila Times
Profusa announces listing transfer to the Nasdaq Capital Market - marketscreener.com
Digital health company Profusa shifts Nasdaq tier to meet listing rules - Stock Titan
Profusa granted transfer to Nasdaq Capital Market, faces July compliance deadline - MSN
Profusa announces initial $1 million bitcoin investment to initiate its digital asset treasury strategy - MSN
Profusa Inc (PFSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):